Pharmaceuticals
Healthcare
Temasek tastes a lemon while True North makes a forgettable PE exit
Homegrown private equity firm True North and Singaporean sovereign wealth fund Temasek are exiting a healthcare ......
Healthcare
Samarsh Capital, others hit jackpot as pharma portfolio firm eyes $182 mn tag
Small & medium enterprises (SME)-focused private equity firm Samarsh Capital that had led an investment round in a ......
Healthcare
How did Quadria Capital fare in exit from six-year-old India portfolio company?
Healthcare-focused private equity firm Quadria Capital, which made the final close of its third fund with $1.07 billion (......
Healthcare
Rivendell signing off from a legacy India PE bet with a haircut
Private equity firm Rivendell PE, which was co-founded by Parag Saxena and Rajat Gupta, former McKinsey chief who faced ......
Healthcare
Can TPG beat exit benchmark as IPO-bound portfolio firm targets rich valuation?
Private equity firm TPG has set the ball rolling to monetize its investment in another Indian company, as it extends ......
Healthcare
ADIA joining cap table of Indian pharmaceutical platform
Abu Dhabi Investment Authority (ADIA), one of the most active sovereign funds operating in India striking both private ......
Healthcare
QHP Capital strikes an India-linked bolt-on deal; local PE firm gets an exit
QHP Capital, which started as a corporate venture arm of Quintiles (now IQVIA) and later spun out as NovaQuest that ......
